A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study-Reference-Cited by-同舟云学术

A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study

Published:2023-08 Issue:5 Volume:19 Page:e414-e422
ISSN:1969-6213
Container-title:EuroIntervention
language:
Short-container-title:

Author:

Haude Michael,Wlodarczak Adrian,van der Schaaf René J.,Torzewski Jan,Ferdinande Bert,Escaned Javier,Iglesias Juan F,Bennett Johan,Toth Gabor G.,Joner Michael,Toelg Ralph,Wiemer Marcus,Olivecrano Göran,Vermeersch Paul,Garcia-Garcia Hector M.,Waksman Ron

Publisher

Europa Digital & Publishing

Subject

Cardiology and Cardiovascular Medicine

Reference22 articles.

1. SICI-GISE Position Document on the Use of the Magmaris Resorbable Magnesium Scaffold in Clinical Practice

2. Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients withde novocoronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial

3. Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds

4. Sustained Safety and Efficacy of Magnesium Reabsorbable Scaffold: 2-Year Follow-Up Analysis From First Magmaris Multicenter Italian Registry

5. BIOSOLVE‐IV ‐registry: Safety and performance of the Magmaris scaffold: 12‐month outcomes of the first cohort of 1,075 patients

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sirolimus-eluting iron bioresorbable scaffold versus cobalt-chromium everolimus-eluting stents in patients with coronary artery disease: Rationale and design of the IRONMAN-II trial;American Heart Journal;2024-09

2. Serial intracoronary imaging to predict efficacy and safety of magnesium-based resorbable scaffolds;EuroIntervention;2024-09

3. A new resorbable magnesium scaffold (DREAMS 3G): 12-month vasomotion results from the BIOMAG-I first-in-human study;EuroIntervention;2024-09

4. Vascular response following implantation of the third-generation drug-eluting resorbable coronary magnesium scaffold: an intravascular imaging analysis of the BIOMAG-I first-in-human study;EuroIntervention;2024-09

5. Long-term outcomes following bioresorbable vascular scaffolds;Expert Review of Cardiovascular Therapy;2024-07-30